For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 Dose of Certain Phase IIb Clinical Research
Phase of Trial: Phase II
Latest Information Update: 25 Mar 2017
At a glance
- Drugs Mycobacterium riyadhense (Primary) ; Tuberculin
- Indications Tuberculosis
- Focus Diagnostic use; Pharmacodynamics
- Sponsors AnHui Longcom Biologic Pharmacy
- 14 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 03 Mar 2015 Planned End Date changed from 1 May 2015 to 1 Jul 2015, according to ClinicalTrials.gov record.
- 03 Mar 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Apr 2015, according to ClinicalTrials.gov record.